Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF
Baylor University Medical Center, Dallas, Texas
Estimated time of Talk
This webcast will overview the heart failure epidemic and biomarker technology currently available to improve patient management and outcomes.
- Review the classical assessment for the identification of heart failure
- Understand the pathophysiology that drives the initiation and development of heart failure
- Distinguish Galectin-3 and NT-proBNP as complementary biomarkers of heart failure
- Review the role of Galetin-3 in the identification and management of heart failure
Primary Care Physicians, Internal Medicine and, Specialists
Conflicts of Interest
Dr. McCullough is a consultant for BG Medicine, Inc.